Investigation of pulmonary hypertension in patients receiving tyrosine kinase inhibitors
Not Applicable
- Conditions
- Chronic myelogenous leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia
- Registration Number
- JPRN-UMIN000016857
- Lead Sponsor
- Kyushu university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Unable to obtain the consent.
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of tyrosine kinase inhibitor induced pulmonary hypertension.
- Secondary Outcome Measures
Name Time Method Risk factors associated with tyrosine kinase inhibitor induced pulmonary hypertension.